The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review
- PMID: 20452051
- DOI: 10.1016/j.psychres.2008.07.025
The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review
Abstract
Patients with schizophrenia suffer from impairments in facial affect recognition and social functioning. Since antipsychotic medication affects different areas in the brain, they may also affect target areas involved in emotional processing mechanisms. In this article, we review the findings of the effect of antipsychotic medication on facial affect recognition in schizophrenia. We searched PubMed for articles in English with the keywords schizophrenia, facial, affect, emotion, antipsychotic and medication, published till January 2008. Eight relevant articles were found describing original studies. No substantial improvements in facial affect recognition were found after treatment with either typical or atypical antipsychotic drugs. Facial affect recognition was not related to neuropsychological functioning, and it was unclear whether improvement of symptom severity was related to performance on the facial affect recognition tasks. It is recommended that future research should focus on measuring social skills and social functioning more directly, and by investigating the effects of additional behavioural treatments on facial affect recognition and social functioning relative to treatment with antipsychotic medication alone.
Similar articles
-
Antipsychotic medication and social cue recognition in chronic schizophrenia.Psychiatry Res. 2010 Jun 30;178(1):46-50. doi: 10.1016/j.psychres.2010.04.006. Epub 2010 May 8. Psychiatry Res. 2010. PMID: 20452678
-
Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study.World J Biol Psychiatry. 2009;10(4 Pt 3):719-28. doi: 10.1080/15622970701432536. World J Biol Psychiatry. 2009. PMID: 17853271 Clinical Trial.
-
Facial recognition deficits and cognition in schizophrenia.Schizophr Res. 2004 May 1;68(1):27-35. doi: 10.1016/S0920-9964(03)00131-2. Schizophr Res. 2004. PMID: 15037337
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
Symptom domains of schizophrenia: the role of atypical antipsychotic agents.J Psychopharmacol. 2006 Nov;20(6 Suppl):6-19. doi: 10.1177/1359786806071237. J Psychopharmacol. 2006. PMID: 17046984 Review.
Cited by
-
Randomized Clinical Trial with e-MotionalTraining® 1.0 for Social Cognition Rehabilitation in Schizophrenia.Front Psychiatry. 2018 Feb 26;9:40. doi: 10.3389/fpsyt.2018.00040. eCollection 2018. Front Psychiatry. 2018. PMID: 29535646 Free PMC article.
-
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.Med Sci Monit. 2012 Jan;18(1):CR44-49. doi: 10.12659/msm.882202. Med Sci Monit. 2012. PMID: 22207119 Free PMC article.
-
Facial affect processing deficits in schizophrenia: a meta-analysis of antipsychotic treatment effects.J Psychopharmacol. 2015 Feb;29(2):224-9. doi: 10.1177/0269881114560184. Epub 2014 Dec 9. J Psychopharmacol. 2015. PMID: 25492885 Free PMC article.
-
Differences in Facial Emotion Recognition between First Episode Psychosis, Borderline Personality Disorder and Healthy Controls.PLoS One. 2016 Jul 28;11(7):e0160056. doi: 10.1371/journal.pone.0160056. eCollection 2016. PLoS One. 2016. PMID: 27467692 Free PMC article.
-
Emotion Processing and Its Relationship to Social Functioning and Symptoms in Psychotic Disorder: A Systematic Review and Meta-analysis.Schizophr Bull. 2025 Jul 7;51(4):1054-1071. doi: 10.1093/schbul/sbae167. Schizophr Bull. 2025. PMID: 39360974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical